PR Newswire (Thu, 1:00PM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
4,685 people get CVS articles and Market Currents by email alert.
Get email alerts on CVS »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 13, 2013)
-
-
-
PR Newswire (May 9, 2013)
-
-
-
PR Newswire (May 1, 2013)
-
-
PR Newswire (Apr 30, 2013)
-
Regulation To Drive Pharmacy SpecializationTom Luongo • Fri, Apr 26
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Why We Like CVS CaremarkUlfberht Capital • Mon, Apr 8 -
-
-
-
-
-
-
-
-
-
Earnings Analysis: CVS CaremarkCapitalCube • Wed, Nov 7, 2012 -
Watch For Walgreen-Express Scripts Impact In CVS Caremark EarningsTrefis • Mon, Nov 5, 2012
-
-
-
-
-
CVS: Demographics And Business Model Mean Tons Of Upside For The StockMike Williams • Thu, Aug 16, 2012
-
CVS Caremark's CEO Hosts 2012 Analyst Day (Transcript)Thu, Dec 13, 2012
-
CVS Caremark's CEO Discusses Q4 2011 Results - Earnings Call TranscriptWed, Feb 8, 2012 • 1 Comment
-
CVS Caremark Corporation - Analyst/Investor DayTue, Dec 20, 2011
-
CVS Caremark's CEO Discusses Q3 2011 Results - Earnings Call TranscriptThu, Nov 3, 2011 • 1 Comment
-
CVS Caremark Corporation Q2 2010 Earnings Call TranscriptThu, Jul 29, 2010
-
CVS Caremark Q1 2010 Earnings Call TranscriptTue, May 4, 2010
-
CVS Caremark Corporation Q4 2009 Earnings Call TranscriptMon, Feb 8, 2010
-
CVS Caremark Q3 2009 Earnings Call TranscriptThu, Nov 5, 2009
-
CVS Caremark Q2 2009 Earnings Call TranscriptTue, Aug 4, 2009
-
CVS Caremark Corporation Q1 2009 Earnings Call TranscriptTue, May 5, 2009
-
PR Newswire (Thu, 1:00PM)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 13, 2013)
-
at Fox Business (May 13, 2013)
-
PR Newswire (May 9, 2013)
-
at MarketWatch.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at Fox Business (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
PR Newswire (May 1, 2013)
-
at CNBC.com (Apr 30, 2013)
-
PR Newswire (Apr 30, 2013)
-
at MarketWatch.com (Apr 28, 2013)
-
at CNBC.com (Apr 26, 2013)
-
at CNBC.com (Apr 20, 2013)
CVS vs. ETF Alternatives
Company Description
CVS Caremark Corporation (“CVS Caremark”, the “Company”, “we” or “us”) is the largest pharmacy health care provider in the United States. As a fully integrated pharmacy services company, we believe we can drive value for our customers by effectively managing pharmaceutical costs and improving... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, November 23, 2011, 1:51 PM Express Scripts (ESRX +1.9%) and Medco Health (MHS +1.2%) are joining Walgreen (WAG +5.2%) in spiking higher on the rumor that Walgreen and Express Scripts will come to terms on a new prescription-claims deal. CVS (CVS -1.1%) has sold off slightly. Comment! [Healthcare, On the Move]
- Tuesday, November 15, 2011, 11:59 AM Several names are outperforming today after Berkshire Hathaway's (BRK.A, BRK.B) latest 13-F disclosed Warren Buffett's company had bought shares in them (I, II). INTC +1.4%. CVS +0.5%. V +0.8%. DTV +1.2%. DG +1%. Comment! [On the Move]
- Monday, November 14, 2011, 5:39 PM More from Warren Buffett: Berkshire Hathaway (BRK.A) discloses owning 5.66M shares of CVS Caremark (CVS), valued at $190M at the end of Q3, and $179M worth of DirecTV (DTV) Class A stock as of Sept. 30, according to a 13-F filing. (earlier: I, II) 2 Comments [Healthcare, Tech]
- Friday, November 4, 2011, 4:10 PM CVS Caremark (CVS +1.9%) finishes higher on a Morgan Stanley upgrade to Overweight earlier today. Morgan says the company has improved pharmacy benefit management margins and is set for multiple expansion and strong earnings growth in 2012. Comment! [Healthcare, On the Move, Quick Ideas]
- Thursday, November 3, 2011, 7:50 AM More on CVS' (CVS) Q3 report: Pharmacy Services sale increased 26% Y/Y, led by Aetna contract and business from Universal American acquisition. Retail Pharmacy sales up 3.8%, gains tied to Maintenance Choice program offset partially by negative impact from generic introductions. Narrows guidance for full-year EPS to higher end of previous range. Affirms full-year cash flow from operations of a range of $5.5B-$5.6B. (PR) Comment! [Earnings]
- Thursday, November 3, 2011, 7:29 AM CVS Caremark (CVS): Q3 EPS of $0.70 beats by $0.02. Revenue of $26.7B (+10% Y/Y) in-line. (PR) Comment! [Earnings]
- Thursday, November 3, 2011, 12:05 AM Notable earnings before Thursday's open: AGU, ANF, ANR, APA, ARIA, BEAM, CNQ, CVS, DNR, DTV, DUK, EGO, EL, FIG, FTR, HCN, K, LAMR, LXP, MFA, MFC, MGA, MGM, MT, NNN, NRG, NYX, PCG, PGN, PNM, PPL, REGN, RGLD, SE, SLE, SNI, SPR, SRE, SU, TDC, TEL, TS, VRX, WNR, XEC Comment! [Earnings]
- Monday, October 24, 2011, 12:01 PM Citi's Deborah Weinswig is urging clients to buy CVS ahead of next Thursday's Q3 report. Weinswig expects CVS to post strong same-store sales growth on account of customers transferring their prescriptions from rival Walgreen (WAG), as the latter continues to negotiate with Express Scrips (ESRX) regarding a new deal. Comment! [Healthcare, Quick Ideas]
- Wednesday, October 5, 2011, 8:44 AM Shares of Walgreen (WAG) lose 1.4% premarket after the firm reports September sales rose a brisk 5.4% Y/Y to $5.95B. A mild flu season (so far) negatively impacted prescription sales and flu shots for the month. Rivals: RAD +1%, CVS unchanged. Comment! [On the Move]
- Monday, October 3, 2011, 3:16 PM Aetna (AET) and CVS will jointly offer a Medicare prescription drug plan, the latest such arrangement between a health insurer and a drugstore chain. The program's cost will be a $26 monthly plan premium, with no deductible, for generic drugs. Humana began a similar partnership with Wal-Mart (WMT) last year, while Coventry (CVH) has deals with Wal-Mart, Target (TGT) and Walgreen (WAG). Comment! [Healthcare]
- Tuesday, September 27, 2011, 8:57 AM AmerisourceBergen (ABC) will acquire CVS Caremark's (CVS) TheraCom unit for $250M, expanding the drug wholesaler's consulting services offerings and pharmacy benefit reimbursement capabilities. TheraCom generates ~$700M in annual revenue, and the deal is expected to slightly boost ABC's 2013 earnings. Comment! [Healthcare, M&A]
- Sunday, September 18, 2011, 9:04 AM Blue chips such as Microsoft (MSFT), Mellon Bank (BK), CVS, and Exxon (XOM) - "world-dominating ... well-financed and adaptive" - are catching the eye of Jim Grant, but Treasuries aren't. "People are flying for safety into a class of security denominated in the very paper money that others are flying from ... Somebody has not gotten the memo." 41 Comments [Quick Ideas, U.S. Economy]
- Wednesday, August 24, 2011, 9:05 AM CVS Caremark (CVS) announces a $4B stock buyback program on top of an earlier $2B buyback. The drugstore operator says it will repurchase at least $1B in stock by the end of the year. Shares +2.1% premarket. Comment! [On the Move, Consumer]
- Tuesday, August 23, 2011, 9:48 AM Drugstore companies are in the spotlight today of analysts. Barclays lowers its rating on shares of Walgreen's (WAG -3.1%) to Underweight from Equalweight, while Citi slashes price targets on CVS Caremark (CVS +0.2%) to $41 from $46 and on WAG to $42 from $48. 1 Comment [Consumer]
- Thursday, August 4, 2011, 8:41 AM More on CVS Caremark (CVS -2.8%) Q2s. Net profit of $816M was $4M below last year; retail pharmacy revs +3.6% to $14.8B; pharmacy services revs +23.2% to $14.6B. Modifies EPS guidance to $2.75-$2.81 vs. prior forecast of $2.72-$2.82 and analyst expectations of $2.78. (PR) Comment! [Earnings, Healthcare]
- Thursday, August 4, 2011, 7:36 AM More on CVS' (CVS) Q2 report: Pharmacy services revenue $14.6B (+23.2% Y/Y) on strength of long-term contract with Aetna and acquisition. Increases free cash flow $800M, up to $2.4B YTD. Narrows FY11 EPS guidance to $2.75-$2.81, from earlier $2.72-$2.82. (PR) Comment! [Earnings, On the Move]
-
- View all 0 replies
-
- View all 4 replies
-
Eric Stalee: Tomorrow could still be up though if Italy actually succeeds in selling off 7 billion of bonds. But that's probably unrealistic. -
-
- View all 0 replies
-
- View all 0 replies
-
- View all 8 replies
-
losbronces: or better for CVS before January. Or keep the premium and get $37 on your CVS if its still there in January. -
dak269: Thanks! I had originally sold a $35 strike, bought it back to sell the $37. I'm a little bearish, so I'll probably just sit on it. No rush
-
- View all 0 replies
-
- View all 0 replies
-
Chuck Carnevale
$CVS - what does CVS' valuation look like? Review F.A.S.T. Graphs: http://bit.ly/vqQewc - View all 1 replies
-
sstonerm3: Looks slightly undervalued to me. Doesn't scream buy at this point.
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES